SELLAS Life Sciences
SLS
SLS
16 hedge funds and large institutions have $2.07M invested in SELLAS Life Sciences in 2018 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
33% less funds holding
Funds holding: 24 → 16 (-8)
62% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 13
Holders
16
Holding in Top 10
–
Calls
$477K
Puts
$11K
Top Buyers
| 1 | +$1.27M | |
| 2 | +$318K | |
| 3 | +$307K | |
| 4 |
Morgan Stanley
New York
|
+$144K |
| 5 |
VF
Virtu Financial
New York
|
+$60.2K |
Top Sellers
| 1 | -$31K | |
| 2 | -$30K | |
| 3 | -$29K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$18K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$10K |